中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
CHINESE JOURNAL OF GENERAL SURGERY
2012年
8期
619-622
,共4页
郭丰丽%林秋生%魏丽娟%赵晶%刘俊田
郭豐麗%林鞦生%魏麗娟%趙晶%劉俊田
곽봉려%림추생%위려연%조정%류준전
乳腺肿瘤%肿瘤,未知原发灶%预后%淋巴转移
乳腺腫瘤%腫瘤,未知原髮竈%預後%淋巴轉移
유선종류%종류,미지원발조%예후%림파전이
Breast neoplasms%Neoplasms,unknown primary%Prognosis%Lymphatic metastasis
目的 分析隐匿性乳腺癌的临床特征及预后影响因素.方法 回顾性分析天津市肿瘤医院1997年10月至2011年10月收治的62例隐匿性乳腺癌的临床病理资料,对其临床特征及影响预后的因素进行分析.结果 62例隐匿性乳腺癌患者3、5、10年总生存率分别为87.4％、76.4％、73.2％；中位生存期为53个月.阳性淋巴结数目＞4个的患者3、5、10年总生存率低于阳性淋巴结数目≤4个者(77.8％、64.8％、38.9％比90.7％、86.7％、86.7％,P=0.015).乳腺癌根治术后病理切片发现原发灶组3、5、10年总生存率低于未发现原发灶组(60.0％、40.0％、40.0％比92.0％、83.6％、79.2％,P=0.023).有复发转移组总生存率低于无复发转移组(63.5％、28.6％、19.0％比97.1％、97.1％、97.1％,P=0.000).结论 隐匿性乳腺癌预后与阳性淋巴结数、乳腺病理切片能否发现原发灶以及有无复发转移有关.
目的 分析隱匿性乳腺癌的臨床特徵及預後影響因素.方法 迴顧性分析天津市腫瘤醫院1997年10月至2011年10月收治的62例隱匿性乳腺癌的臨床病理資料,對其臨床特徵及影響預後的因素進行分析.結果 62例隱匿性乳腺癌患者3、5、10年總生存率分彆為87.4％、76.4％、73.2％；中位生存期為53箇月.暘性淋巴結數目＞4箇的患者3、5、10年總生存率低于暘性淋巴結數目≤4箇者(77.8％、64.8％、38.9％比90.7％、86.7％、86.7％,P=0.015).乳腺癌根治術後病理切片髮現原髮竈組3、5、10年總生存率低于未髮現原髮竈組(60.0％、40.0％、40.0％比92.0％、83.6％、79.2％,P=0.023).有複髮轉移組總生存率低于無複髮轉移組(63.5％、28.6％、19.0％比97.1％、97.1％、97.1％,P=0.000).結論 隱匿性乳腺癌預後與暘性淋巴結數、乳腺病理切片能否髮現原髮竈以及有無複髮轉移有關.
목적 분석은닉성유선암적림상특정급예후영향인소.방법 회고성분석천진시종류의원1997년10월지2011년10월수치적62례은닉성유선암적림상병리자료,대기림상특정급영향예후적인소진행분석.결과 62례은닉성유선암환자3、5、10년총생존솔분별위87.4％、76.4％、73.2％；중위생존기위53개월.양성림파결수목＞4개적환자3、5、10년총생존솔저우양성림파결수목≤4개자(77.8％、64.8％、38.9％비90.7％、86.7％、86.7％,P=0.015).유선암근치술후병리절편발현원발조조3、5、10년총생존솔저우미발현원발조조(60.0％、40.0％、40.0％비92.0％、83.6％、79.2％,P=0.023).유복발전이조총생존솔저우무복발전이조(63.5％、28.6％、19.0％비97.1％、97.1％、97.1％,P=0.000).결론 은닉성유선암예후여양성림파결수、유선병리절편능부발현원발조이급유무복발전이유관.
Objective To analyze the clinical features and prognostic factors of occult breast cancer. Methods The clinical features and prognostic factors of 62 occult breast cancer patients,who were treated in Tianjin Cancer Hospital from October 1997 to October 2011,were retrospectively analyzed.Results The 3-year,5-year and 10-year overall survival rates of 62 cases were 87.4％,76.4％,73.2％ respectively,a median of 53 months.The 3-,5-,and 10-year overall survival rates of the patients with ＞4 positive lymph nodes are lower than that of patients with ≤4 nodes (77.8％,64.8％,38.9％ vs.90.7％,86.7％,86.7％,P =0.015 ) ;The 3-year and 5-year overall survival rates of patients with primary cancer found in removed breast tissue are lower than that in those primary tumor was not found (60.0％,40.0％,40.0％ vs.92.0％,83.6％,79.2％,P =0.023).The 3-year,5-year and 10-year overall survival rates in patients with recurrence and metastasis are lower than that of patients without (63.5％,28.6％,19.0％ vs.97.1％,97.1 ％,97.1％,P =0.000). Conclusions The prognosis of occult breast cancer is related with the number of positive lymph node,pathology,recurrence and metastasis.
